Attention deficit hyperactivity disorder in patients with seizures: Functional seizures vs. epilepsy

Background: We investigated the rates of positive screening for attention deficit-hyperactivity disorder (ADHD) in adults with seizures [i.e., focal epilepsy vs. idiopathic generalized epilepsy (IGE) vs. functional seizures (FS)]. We hypothesized that the rates of positive screening for ADHD are different between these three groups of patients.Methods: This was a cross sectional study. Patients, 19 to 55 years of age, with a diagnosis of IGE, focal epilepsy or FS were investigated at the outpatient epilepsy clinic at Shiraz University of Medical Sciences, Shiraz, Iran, from September 2022 until January 2023 and during their follow-up visits. We used the validated Persian version of Adult ADHD Self-Report Scale (ASRS v1.1)15 to investigate and screen for ADHD in these patients.Results: Forty patients with focal epilepsy, 40 with IGE, and 40 with FS were included. Attention deficit -hyperactivity disorder (ADHD) screening was positive in 35% of patients with FS, in 30% of those with focal epilepsy (compared with FS, p = 0.633), and in 10% of patients with IGE (compared with FS, p = 0.007).Conclusion: Adult patients with functional seizures and those with focal epilepsy are at a high risk of self -reporting experiences that could be characteristic of ADHD. Screening tools [e.g., Adult ADHD Self-Report Scale (ASRS v1.1)] are useful to help clinicians address seizure comorbidities such as ADHD. However, a clin-ical diagnosis of ADHD should be ascertained in a patient with positive screening.

Automated summary

We investigated the rates of positive screening for ADHD in adults with different types of seizures. The screening results showed that 35% of patients with functional seizures, 30% of those with focal epilepsy, and 10% of patients with idiopathic generalized epilepsy had positive ADHD screening results. This suggests that adult patients with functional seizures and focal epilepsy have a higher risk of ADHD symptoms.